Email this article to a friend
A randomized, double blind, placebo and active comparator controlled pilot study of UP446, a novel dual pathway inhibitor anti-inflammatory agent of botanical origin
Nutrition Journal 2012, 11:21 doi:10.1186/1475-2891-11-21
